Good morning, everyone. Damian Garde here, filling in for Ed Silverman at the outset of yet another working week. Here’s hoping the travails of your day tend toward the painless. Below are a few items to get you started, and, as always, if you hear something curious, do let us know. …
GSK appointed Julie Brown, formerly of Burberry, to serve as its chief financial officer, the company’s first female CFO, Bloomberg tells us. Brown previously worked at AstraZeneca and the medical device firm Smith & Nephew and served on the board of Roche. She replaces the retiring Iain Mackay, who was at GSK for four years.
Pfizer and BioNTech are asking the U.S. Food and Drug Administration to authorize their Omicron-specific booster shots for children between 5 and 11, Reuters reports. The news comes a few days after Moderna filed an FDA application for its updated boosters, which the Centers for Disease Control and Prevention said would be available for kids in October. The new boosters, which target both the original strain of the virus and the circulating BA.4 and BA.5 subvariants of Omicron, have so far seen a slow uptake in the U.S.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect